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Introduction
Neuronal ceroid lipofuscinoses (NCLs) are autosomal reces­
sive disorders that lead to progressive neurodegeneration and 
early death in humans (Mole et al., 2005; Kyttälä et al., 2006; 
Siintola et al., 2006). NCLs are typified by the accumulation 
of autofluorescent material in the lysosome followed by sub­
sequent neuron loss and result from mutations in genes encod­
ing lysosomal enzymes or transmembrane domain (TMD)– 
containing proteins of unknown function possibly connected 
to protein palmitoylation (Phillips et al., 2005; Kyttälä et al., 
2006; Siintola et al., 2006; Rakheja et al., 2008; Getty and 
Pearce, 2011). For example, CLN1, which is involved in in­
fantile NCL, encodes a palmitoyl protein thioesterase (Vesa 
et  al.,  1995;  Kyttälä  et  al.,  2006).  More  recently,  CLN3, 
which is involved in juvenile­onset NCL or Batten disease, 
was suggested to encode a palmitoyl protein ­9 desaturase pre­
dicted to convert palmitoylated protein substrates into palmi­
toylated derivatives (Narayan et al., 2006; Rakheja et al., 2008). 
How defects in these genes lead to neurodegeneration is un­
known, and the connection between NCL­related proteins, protein 
palmitoylation, and identity of the palmitoylated substrates 
is obscure.
Some genes associated with NCLs are conserved. The 
best example is CLN3, which has a yeast orthologue called 
BTN1  (see  Table  S9  for  name  description;  Pearce  and   
Sherman, 1997; Croopnick et al., 1998). The deletion of BTN1 
in Saccharomyces cerevisiae yields defects in vacuolar pH 
homeostasis, amino acid uptake to the vacuole, vacuolar­type 
H
+–ATPase  (V­ATPase)–dependent  H
+  transport,  and  nitric 
oxide signaling and leads to the up­regulation of BTN2, a 
gene possibly involved in cellular adaptation to the loss of 
BTN1  (Pearce  et  al.,  1999;  Chattopadhyay  et  al.,  2000;   
Chattopadhyay and Pearce, 2002; Padilla­López and Pearce, 
2006; Osório et al., 2007). Although Btn1 is proposed to lo­
calize to and act at the level of the vacuole (Croopnick et al., 
1998; Pearce and Sherman, 1998, 1999; Pearce et al., 1999; 
Gachet et al., 2005; Kim et al., 2005; Wolfe et al., 2011), 
T
he  human  Batten  disease  gene  CLN3  and  yeast   
orthologue BTN1 encode proteins of unclear function. 
We show that the loss of BTN1 phenocopies that of 
BTN2, which encodes a retromer accessory protein in-
volved in the retrieval of specific cargo from late endo-
somes (LEs) to the Golgi. However, Btn1 localizes to Golgi 
and regulates soluble N-ethyl-maleimide sensitive fusion 
protein attachment protein receptor (SNARE) function to 
control retrograde transport. Specifically, BTN1 overexpres-
sion and deletion have opposing effects on phosphory-
lation of the Sed5 target membrane SNARE, on Golgi 
SNARE assembly, and on Golgi integrity. Although Btn1 
does not interact physically with SNAREs, it regulates Sed5 
phosphorylation  by  modulating  Yck3,  a  palmitoylated   
endosomal kinase. This may involve modification of the 
Yck3 lipid anchor, as substitution with a transmembrane 
domain suppresses the deletion of BTN1 and restores traf-
ficking. Correspondingly, deletion of YCK3 mimics that of 
BTN1 or BTN2 with respect to LE–Golgi retrieval. Thus, 
Btn1  controls  retrograde  sorting  by  regulating  SNARE 
phosphorylation and assembly, a process that may be   
adversely affected in Batten Disease patients.
The yeast Batten disease orthologue Btn1  
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Results
The deletion of BTN1 results in the 
mislocalization of Yif1 and Kex2
The loss of BTN2 results in the mislocalization of a trans­Golgi 
protein, Yif1, to the vacuole (Chattopadhyay et al., 2003; Kama 
et al., 2007), where it is degraded (Kama et al., 2007). As BTN2 
is up­regulated in the absence of BTN1 and because Btn2 acts 
upon  LE–Golgi  sorting,  we  determined  whether  Btn1  is  in­
volved  in  transport.  We  examined  the  localization  of  GFP­
tagged Yif1 in wild­type (WT) cells or cells lacking either BTN1 
or BTN2 (Fig. 1 A). In WT cells, GFP­Yif1 labeled small punc­
tate structures that correspond to Golgi (Matern et al., 2000) 
and did not colabel with FM4­64 (Fig. 1 A and Table S1), a dye 
that labels endosomes and then vacuoles. In contrast, GFP­Yif1 
mislocalized to vacuoles in btn2 cells, as previously shown 
(Chattopadhyay et al., 2003; Kama et al., 2007), and to FM4­64–
labeled compartments situated adjacent to the vacuole (along 
with limited vacuolar labeling) in btn1 cells (Fig. 1 A and 
Table S1). The nonvacuolar compartments labeled by GFP­Yif1 
in btn1 cells are likely to be LEs, as they colabeled with RFP­
tagged Vps27 (Fig. 1 B), a protein involved in the multivesicu­
lar body (MVB) pathway (Piper et al., 1995). Thus, the deletion 
of BTN1 affects Yif1 localization in a manner similar to the de­
letion of BTN2. Importantly, Yif1 localization to the Golgi was 
almost fully restored to btn1 cells by expression of the human 
CLN3 gene (Fig. 1 A [bottom] and Table S1). Thus, the function 
of these orthologues may be conserved.
Next, we examined whether GFP­tagged Kex2, a protease 
retrieved to the trans­Golgi via LEs in WT cells (Brickner and 
Fuller, 1997), is mislocalized in btn1 cells (Fig. 1 C). Kex2 
accumulates at LEs in btn2 cells, and its mislocalization 
results in a loss in the secretion of active ­mating factor 
(Kanneganti et al., 2011). We found that Kex2­GFP accumu­
lates in large LE­like structures that label with FM4­64 and are 
situated adjacent to the vacuole in both btn1 and btn2 cells 
(Fig. 1 C and Table S2). This indicates that Kex2 is not effi­
ciently retrieved to the Golgi in the absence of either Btn1 or 
Btn2. Interestingly, Kex2 also relocalized to the Golgi when the 
CLN3 was overexpressed in btn1 cells (Fig. 1 C and Table S2). 
Together, these results suggest that both Btn1 and Btn2 act upon 
LE–Golgi protein sorting.
To show specificity, we examined the localization of other 
proteins that undergo sorting on the secretory pathway in cells 
lacking BTN1 (Fig. S1 A). These proteins (see Table S9) in­
cluded GFP­tagged Snx4 (Hettema et al., 2003), Vps27, Vps10 
(Deloche and Schekman, 2002), Tlg1 (Coe et al., 1999), Tlg2 
(Abeliovich et al., 1998; Holthuis et al., 1998), Snc1 (Protopopov 
et al., 1993; Gurunathan et al., 2000), Fur4 (Bugnicourt et al., 
2004), Ste2 (Stefan and Blumer, 1999), and CPY. However, we 
did not observe significant changes in their localization when 
expressed (from single­copy plasmids) in btn1 cells in com­
parison with WT cells (Fig. S1 A). This result was identical to 
that observed for btn2 cells (Kama et al., 2007). We also ex­
amined CPY secretion, which occurs as a result of defects in 
vacuolar protein sorting. Although CPY was detected on filters 
where cells lacking VPS10 or VPS26 (which encode retromer 
many of these studies used gene overexpression, which often 
results  in  protein  mislocalization.  Recent  studies  suggest 
that Btn1 might localize to the Golgi in S. cerevisiae (Vitiello 
et al., 2010) and Schizosaccharomyces pombe (Codlin and 
Mole, 2009).
We previously demonstrated that Btn2, which has simi­
larity to the Hook family of coiled­coil proteins associated 
with endosomal processes (Krämer and Phistry, 1996; Sunio 
et al., 1999; Walenta et al., 2001; Richardson et al., 2004),   
localizes to late endosomes (LEs) and mediates the retrieval of 
specific cargo proteins from LEs to the Golgi (Kama et al., 
2007). Btn2 binds to components involved in LE–Golgi pro­
tein retrieval, such as elements of the retromer complex (e.g., 
Vps26) and the Snc1/2 exo/endocytic vesicle SNAREs. More­
over, it forms a complex between a retrieved cargo protein 
(e.g., Yif1), the endocytic SNARE complex (e.g., Snc1/2, Vti1, 
Tlg1, and Tlg2), retromer (e.g., Vps5, 17, 26, 29, and 35), and 
a sorting nexin (e.g., Snx4; Kama et al., 2007). This complex 
is specific to a subset of LE–Golgi­retrieved proteins because 
Vps10, the carboxypeptidase Y (CPY) receptor, cannot be co­
precipitated with Btn2 and is not mislocalized in btn2 cells. 
This contrasts to mutants defective in retromer, Snx4, or Ypt6 
(a Rab involved in LE–Golgi transport) that mislocalize both 
Vps10 and CPY. Thus, multiple routes may be involved in 
LE–Golgi protein retrieval, and Btn2 may be specific to one 
(Kama et al., 2007). Interestingly, Btn2 also facilitates prion 
curing, indicating a potential role in the targeting of misfolded 
protein aggregates for degradation (Kryndushkin et al., 2008). 
Recently, we demonstrated that Btn2 can localize to the insol­
uble protein deposit compartment (Bagola and Sommer, 2008; 
Kaganovich et al., 2008) thought to be involved in prion seques­
tration and identified Btn3 as a negative regulator of Btn2­ 
mediated LE–Golgi transport and prion curing (Kanneganti   
et al., 2011).
Given  the  connection  between  Btn2  and  LE–Golgi 
transport, we examined whether Btn1 acts upon protein re­
trieval. We find that BTN1 encodes a Golgi protein involved 
in the regulation of SNARE phosphorylation and assembly 
and controls LE–Golgi and intra­Golgi protein sorting. The 
deletion of BTN1 phenocopies the loss of BTN2, resulting in 
the mislocalization of Yif1 and Kex2, and can be comple­
mented by the heterologous expression of human CLN3. This 
suggests that the biochemical function of Btn1/Cln3 is con­
served.  Specifically,  BTN1  overexpression  or  deletion  has 
opposing effects upon SNARE assembly and Golgi morphol­
ogy,  which  are  mediated  through  Sed5,  a  SNARE  whose 
control of retrograde protein trafficking and Golgi morphol­
ogy is sensitive to phosphorylation (Weinberger et al., 2005). 
Btn1 appears to regulate the phosphorylation of Sed5 via 
Yck3,  a  palmitoylated  kinase  involved  in  Golgi–vacuole 
transport (Sun et al., 2004) and whose deletion phenocopies 
btn1 or btn2 cells. The ability of Btn1 to regulate kinase 
function may involve modulation of the palmitate lipid an­
chor, as substitution of the cysteine acceptor region in Yck3 
with a TMD suppresses the loss of BTN1. Thus, Btn1 con­
trols a membrane­anchored kinase that functions in Golgi–
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components; Seaman et al., 1998) were grown, it was not de­
tected where either WT or btn1 cells were grown (Fig. S1 B). 
Thus, in contrast to Yif1 or Kex2, neither CPY sorting nor the 
localization of other trafficked markers was altered in the ab­
sence of BTN1.
To verify the imaging data, we examined properties of 
these proteins that might support the idea that Yif1 and Kex2 are 
mislocalized. First, we examined the stability of GFP­Yif1 by 
Western analysis (Fig. S1 C), as the robust accumulation of free 
GFP was observed in cells lacking BTN2 but not in WT cells 
(Kama et al., 2007). Upon quantification, we found that the 
level of free GFP in btn1 cells was twofold that of WT cells 
but only half as much as that seen in control btn2 cells (un­
published data). Thus, Yif1 does not undergo the same level of 
degradation in btn1 cells as in btn2 cells, but this result paral­
lels the microscopy data showing that 16% of btn1 cells have 
vacuolar labeling, whereas WT and control btn2 cells show 7 
and 32% vacuolar labeling, respectively (Table S1). Next, we 
examined Kex2 function in ­factor maturation by scoring halo 
formation on lawns of sst2 tester cells. We found that the halo 
size (i.e., which delimits the area of mature and active secreted 
­factor) was significantly reduced in the presence of either 
btn1 cells or btn2 cells in contrast to WT cells (e.g., the halo 
diameter was 7.5 mm for the spotted btn1 and btn2 cells vs. 
10 mm for WT cells; n = 2; Fig. S1 D). Thus, Kex2 function is 
reduced in btn1 cells, suggesting that it localizes to a compart­
ment that is unable to access immature ­factor.
Btn1 localizes to the Golgi and is retrieved 
from LEs in a Btn2-dependent manner
The intracellular localization of Btn1 is unclear; GFP­tagged 
Btn1 localizes to the vacuole upon overexpression (i.e., from 
multicopy plasmids; Croopnick et al., 1998; Pearce and Sherman, 
1998, 1999; Pearce et al., 1999; Gachet et al., 2005; Kim et al., 
2005) or to the Golgi in S. cerevisiae (Vitiello et al., 2010) and 
S. pombe (Codlin and Mole, 2009) at lower levels of expres­
sion. We examined the localization of Btn1 tagged at the amino 
terminus with GFP to avoid masking a potential ER export se­
quence present at the carboxy terminus (position 353–357; LNILE) 
and expressed it from the genome or single­copy plasmids. GFP­
Btn1 expressed from the chromosome under a GAL promoter, 
constitutively from a single­copy plasmid via an ADH1 pro­
moter, or endogenously under its own promoter localized to   
numerous small punctate structures that did not colocalize with 
FM4­64 (Fig. 2 A, top, middle, and bottom rows, respectively). 
These structures are likely to be trans­Golgi, as GFP­Btn1 co­
localized with either RFP­tagged Yif1 or Sec7 (Fig. 2 B), which 
are both trans­Golgi markers. In contrast, GFP­Btn1 did not 
overlap with Btn2­RFP (Fig. 2 C), which localizes to LEs (Kama 
et al., 2007). Thus, in contrast to experiments that show Btn1 to 
be vacuolar, we observe Btn1 as a Golgi protein. Moreover, 
GFP­Btn1 localization to the Golgi appears to be mediated by 
LE–Golgi protein retrieval, as GFP­Btn1 was mislocalized to the 
vacuole in cells lacking BTN2 (Fig. 2 D), as with Yif1 or Kex2 
(Fig. 1, A and C). However, we note that GFP-BTN1 overexpres­
sion from multicopy plasmids indeed leads to labeling of the 
vacuole membrane (unpublished data).
Figure 1.  The deletion of BTN1 results in defects in LE–Golgi sorting. (A) Yif1 is   
mislocalized to LEs in cells lacking BTN1. (top) WT (BY4741), btn1, and btn2   
cells expressing GFP-Yif1 from a single-copy plasmid were labeled with FM4-64   
and visualized, as described in Materials and methods. Merge indicates 
merger of the GFP and FM4-64 (i.e., RFP) panels. Light indicates the DIC panel. 
The third row illustrates endosomal labeling seen with Yif1 in the majority of   
btn1 cells, whereas the fourth row illustrates vacuolar labeling. (bottom) btn1   
cells expressing GFP-Yif1 from a single-copy plasmid and Cln3 from a multi-
copy plasmid; cells were labeled as previously described. (B) Yif1 localizes 
to Vps27-labeled endosomes in btn1 cells. WT and btn1 cells expressing 
GFP-Yif1 from a single-copy plasmid and RFP-Vps27 from a multicopy plasmid 
are shown. (C) Kex2 is mislocalized to LEs in cells lacking BTN1. (top) WT, 
btn1, and btn2 cells expressing Kex2-GFP from a single-copy plasmid are 
shown. (bottom) btn1 cells expressing Kex2-GFP from a single-copy plasmid 
and Cln3 from a multicopy plasmid are shown. Bars, 1 µm.JCB • VOLUME 195 • NUMBER 2 • 2011   206
We examined the effect of BTN1 overexpression or deletion in 
mutants of the secretory pathway and found that overexpression 
inhibited the growth of cells bearing temperature­sensitive al­
leles of VTI1, YKT6, and SED5 (Fig. S2, A–C), which encode 
SNAREs involved in endosome–Golgi and intra­Golgi protein 
sorting. This is specific, as BTN1 overexpression had little to no 
effect on the growth of cells bearing a temperature­sensitive 
allele of SEC21, which encodes a COPI component involved in 
retrograde Golgi–ER transport; SEC22, which encodes an   
ER–Golgi SNARE; and either SEC1 or SEC9, which encode an 
exocytic SNARE regulator and SNARE, respectively (Fig. S2 D). 
Thus, the deleterious effects of BTN1 overexpression are limited 
to cells that bear mutations in genes involved in endosome–Golgi 
and intra­Golgi transport. Correspondingly, the deletion of BTN1 
ameliorated growth defects seen in ykt6-1 cells at elevated tem­
peratures (Fig. S2 B). No effect by either the overexpression or 
deletion of BTN1 was observed in WT cells (Fig. S2 E).
BTN1 overexpression and deletion affect 
the assembly of Golgi SNAREs
As Btn1 overproduction impedes the functioning of SNAREs 
specific to Golgi transport steps (e.g., Ykt6 and Sed5; Fig. S2), we 
examined  SNARE  assembly  in  cells  either  overexpressing  or 
lacking BTN1. First, we immunoprecipitated an myc epitope–
tagged temperature­sensitive form of Ykt6 (e.g., Ykt6­1; see   
Materials and methods) from WT and either BTN1­overexpressing 
or btn1 cells. In WT cells grown at permissive temperatures, we 
found that Ykt6­1 readily formed complexes with Sed5 and other 
SNAREs involved in ER–Golgi transport (e.g., Bet1 and Bos1), 
intra­Golgi transport (e.g., Sft1 and Gos1), and endosome–Golgi 
transport  (e.g., Tlg1, Tlg2,  and Vti1)  but  not  with  Sso1/2  or 
Snc1/2, which act primarily upon exocytosis (Fig. 3 A). In con­
trast, BTN1 overexpression greatly reduced Ykt6­1 binding to 
Sed5 as well as to Vti1 and Tlg1 (Fig. 3 A). This indicates that 
SNARE partners involved in endosome–Golgi transport were less 
able to form complexes with Ykt6 upon BTN1 up­regulation.
As Sed5 is an essential SNARE involved in Golgi transport 
(Banfield et al., 1994) and whose binding to Ykt6 was influenced 
by Btn1 (Fig. 3 A), we examined the effect of BTN1 overexpres­
sion or deletion on the ability of Sed5 to assemble into SNARE 
complexes. We immunoprecipitated an HA­tagged form of Sed5 
from WT and either BTN1­overexpressing or btn1 cells. In WT 
cells, Sed5 bound weakly to the Vti1 and Tlg1 endosome–Golgi 
transport SNAREs, the Ykt6, Gos1, and Sft1 intra­Golgi transport 
SNAREs, and the Bos1 ER–Golgi SNARE (Fig. 3 B). In con­
trast, BTN1 overexpression greatly reduced, if not eliminated, 
SNARE binding to Sed5, whereas, correspondingly, the deletion 
of BTN1 greatly enhanced binding (Fig. 3 B). This result is spe­
cific to Vti1, Tlg1, Ykt6, Gos1, Sft1, and Bos1, as Sed5 did not 
bind to the Tlg2, Sso1/2, or Snc1/2 SNAREs under any condi­
tion. Thus, the levels of Btn1 appear to control Sed5 assembly 
into specific SNARE complexes.
BTN1 overexpression or deletion 
modulates Golgi clustering
Previous work revealed that Sed5 undergoes phosphorylation at 
serine 317, which is adjacent to the TMD (Weinberger et al., 2005). 
BTN1 overexpression or deletion affects 
the growth of SNARE mutants
Previously, we demonstrated that BTN2 overexpression amelio­
rates the growth of vti1-11 cells (Kama et al., 2007; Kanneganti 
et al., 2011), which are defective in Golgi to LE/MVB transport 
at elevated temperatures (Fischer von Mollard and Stevens, 1999). 
Figure 2.  Btn1 localizes to the Golgi in a manner dependent on Btn2. 
(A) Btn1 does not colocalize with FM4-64–labeled compartments. (top) 
WT cells expressing GFP-tagged BTN1 from its genomic locus under the 
control of a GAL promoter (GAL integrated [GAL int]) were grown on   
galactose-containing medium and were labeled with FM4-64. (middle) WT 
cells expressing GFP-BTN1 constitutively from a single-copy plasmid (CEN 
plasmid) were grown on glucose-containing medium and were labeled 
with FM4-64. (bottom) WT cells expressing GFP-BTN1 from its genomic 
locus and under the control of the BTN1 promoter were grown on glucose-
containing medium and were labeled with FM4-64. (B) Btn1 colocalizes 
with Yif1. WT cells expressing GFP-BTN1 from its genomic locus under the 
control of a GAL promoter and either RFP-YIF1 from a single-copy plasmid 
(top row) or SEC7-DsRed from a chromosomal integration (bottom row) 
were grown on galactose-containing medium and visualized. (C) Btn1 and 
Btn2 do not colocalize. WT cells expressing GFP-BTN1 from its chromo-
somal locus under the control of a GAL promoter and BTN2-RFP from a 
single-copy plasmid are shown; cells were grown on galactose-containing 
medium. (D) Btn1 is mislocalized to the vacuole in btn2 cells. btn2 cells 
expressing GFP-BTN1 from a single-copy plasmid were grown on glucose-
containing medium and were labeled with FM4-64. Bars, 1 µm.207 Btn1 regulates endosome–Golgi retrograde transport • Kama et al.
numerous variably sized puncta (Fig. 4 A, top row; Weinberger 
et al., 2005), we observed that the deletion of BTN1 led to an 
enhancement of their size (i.e., increased clustering; Fig. 4 A, 
bottom row). In cells expressing Sed5
317A (Fig. 4 B, top row), 
which were previously shown to have greatly enlarged Golgi 
puncta (Weinberger et al., 2005), the deletion of BTN1 yielded 
even larger (although typically fewer) puncta (i.e., supercluster­
ing; Fig. 4 B, bottom row). Similar results were observed in 
btn1 cells expressing Sed5
317D (Fig. 4 C, bottom row), al­
though these puncta were smaller than in the other cells lacking 
BTN1 (Fig. 4, A and B [bottom rows]), probably as a result of 
the enhanced vesiculation exerted by Sed5
317D (Weinberger   
et al., 2005). Conversely, BTN1 overexpression led to smaller 
and more dispersed puncta in all cell types (Fig. 4, A–C [mid­
dle rows]). Thus, Btn1 levels greatly modulate Golgi cluster­
ing. The notable changes in size and number of Golgi puncta 
likely result from an effect that Btn1 has upon native Sed5 that 
is present in the WT background (and expressed from the plas­
mid in Fig. 4 A).
Second, we examined the effect of BTN1 overexpression 
or deletion in WT cells expressing GFP­tagged Sed5, Sed5
317A, 
or Sed5
317D from their genomic loci (i.e., as the sole copy of 
SED5; Fig. 4, D–F). We observed similar results as those seen 
with the plasmid­expressed forms of Sed5 (Fig. 4, A–C), al­
though we note that the size of the Golgi clusters formed in the 
presence of Sed5
317A (Fig. 4 E) and/or in the absence of BTN1 
(Fig. 4, D–F [bottom rows]) was not as dramatic as that ob­
served with plasmid­based SED5 overexpression (Fig. 4, A–C). 
This connection between SED5 expression levels and Golgi   
size was previously observed (Weinberger et al., 2005).
Btn1 regulates the phosphorylation state 
of Sed5
Because the deletion of BTN1 enhances Golgi size (Fig. 4), 
which corresponds to the NP form of Sed5 (Weinberger et al., 
2005), and BTN1 overexpression has an opposite effect that 
corresponds with phosphorylated (P) Sed5 (Weinberger et al., 
2005), we examined Sed5 phosphorylation in cells lacking or 
overexpressing BTN1 by Western blotting with anti­Sed5 anti­
bodies.  Cell  extracts  from  WT,  BTN1­overexpressing,  and 
btn1 cells were resolved on 11.5% acrylamide gels and were 
probed with anti­Sed5 antibodies to reveal the lower (NP) and 
higher (P) molecular mass forms (Weinberger et al., 2005). 
As previously seen, Sed5 can exist in the P form in WT cells 
(Weinberger et al., 2005), and this signal appeared somewhat 
stronger (≥15%) in WT cells overexpressing BTN1 than in WT 
cells (see representative experiment shown in Fig. 5 A, top and 
bottom left). More strikingly, the P form of Sed5 was greatly re­
duced in btn1 cells, and quantification revealed that its levels 
were three­ to fourfold lower than in WT cells after normaliza­
tion for loading (Fig. 5 A, bottom left), although a small reduc­
tion in the levels of Sed5 protein was also apparent. The NP/P 
ratio for Sed5 in WT cells, WT cells overexpressing BTN1, and 
btn1 cells was 2.7:1, 2.2:1, and 5:1 in this representative ex­
periment (NP/P ratio for btn1 cells was 7.2 ± 1.7:1 in four ex­
periments; see Figs. 6 (C and F) and S5 A for similar results). 
Thus, excess Btn1 appears to enhance Sed5 phosphorylation, 
A  constitutive  nonphosphorylated  (NP)  form  of  Sed5  (e.g., 
Sed5
317A) conferred normal Golgi function in terms of protein 
export and retrograde sorting events and readily entered into 
COPI vesicles but greatly enhanced Golgi clustering (Weinberger 
et al., 2005). In contrast, a phosphomimicking mutant (e.g., 
Sed5
317D)  inhibited  retrograde  protein  trafficking  within  the 
Golgi (i.e., leading to Kar2 secretion, defects in Gas1 processing, 
and Sec22 mislocalization) and cell growth and induced Golgi 
vesiculation (Weinberger et al., 2005). Because Sed5 phosphory­
lation regulates Golgi morphology and function, we examined 
whether BTN1 overexpression or deletion has similar effects.
First, we examined the effect of BTN1 overexpression or 
deletion in WT cells expressing GFP­tagged Sed5, Sed5
317A, or 
Sed5
317D from single­copy plasmids (Fig. 4; see Table S3 for 
the percentage of cells having Sed5 in dispersed/clustered 
Golgi). In cells expressing GFP­tagged Sed5, which yielded 
Figure  3.  Overexpression  or  deletion  of  BTN1  has  opposing  effects 
on Golgi SNARE assembly. (A) BTN1 overexpression or deletion affects 
SNARE partnering with Ykt6. WT and btn1 cells expressing myc-tagged 
Ykt6-1 from a single-copy plasmid and WT cells expressing both myc-
tagged Ykt6-1 from a single-copy plasmid and HA-tagged Btn1 from a 
multicopy plasmid were processed for IP with anti-myc antibodies. Samples 
of the TCL were separated by SDS-PAGE in parallel to the IP samples. 
Proteins were detected using antibodies to SNAREs as well as the HA and   
myc epitopes to detect Btn1 and Ykt6-1, respectively. Note that Ykt6 did not 
precipitate Sso, Snc, or Btn1. (B) BTN1 overexpression or deletion affects 
SNARE partnering with Sed5. Control WT and btn1 cells expressing   
HA-Sed5 from a single-copy plasmid and WT cells overexpressing myc-Btn1 
from a multicopy plasmid were grown and processed for IP. Samples of the 
TCL and the IP precipitates were electrophoresed and detected in Western 
blots, as previously described. Note that Sed5 did not precipitate Tlg2, 
Sso1/2, or Btn1.JCB • VOLUME 195 • NUMBER 2 • 2011   208
whereas its absence greatly enhances the NP state. These results 
could account for the changes in the aforementioned Golgi mor­
phology observed (Fig. 4).
Loss of Yck3, a palmitoylated protein 
kinase, leads to defects in LE–Golgi 
retrieval and Golgi clustering
Btn1 encodes a multipass membrane­spanning protein that is 
not a kinase; thus, we determined how it could influence Sed5 
phosphorylation and changes in Golgi morphology. Because 
human CLN3 was proposed, but not independently verified, to 
encode a palmitoyl protein ­9 desaturase of unknown conse­
quence (Narayan et al., 2006, 2008), we hypothesized that it 
might act upon palmitoylated proteins that control Sed5 func­
tion. Although several palmitoylated proteins function at the 
Golgi–endosome in yeast, Yck3 and Hrr25 constitute an essen­
tial  pair  of  palmitoylated  endomembrane­associated  kinases 
(Wang et al., 1996) that could potentially regulate Sed5 phos­
phorylation. Yck3 localizes to vacuolar membranes and regu­
lates  vacuole  biogenesis  by  phosphorylating  proteins  like 
Vps41, a homotypic vacuole fusion and vacuole protein sorting 
complex subunit that localizes to LEs when NP (LaGrassa and 
Ungermann, 2005; Cabrera et al., 2009), and the Vam3 t­SNARE 
that mediates vacuolar fusion (Brett et al., 2008). YCK3 over­
expression inhibits the fusion of fragmented vacuoles (LaGrassa 
and Ungermann, 2005), and palmitoylation is required for both 
function and AP­3–dependent protein sorting to the vacuole 
(Sun et al., 2004). Recently, Yck3 fused to a FYVE domain was 
shown to be sufficient to target the kinase to LEs and to locally 
activate Vps41 (Cabrera et al., 2010).
To determine whether Yck3 acts downstream of Btn1, we 
examined whether Yif1 localization is affected by the deletion 
of YCK3. As in btn1 cells (Fig. 1 A), Yif1 mislocalized to 
large puncta and vacuoles in yck3 cells (Fig. 5 B [top and   
bottom, respectively] and Table S1). These puncta are probably 
LEs because Yif1 colocalized with RFP­tagged Vps27 in yck3 
cells (Fig. 5 C), as previously shown for btn1 cells (Fig. 1 B). 
We also examined whether Kex2 localization is affected by the 
deletion of YCK3 and found that Kex2 was mislocalized to 
large LE­like structures that label with FM4­64 and that are 
situated adjacent to the vacuole (Fig. 5 D and Table S2), as seen 
in btn1 cells (Fig. 1 C). As Kex2 mislocalization leads to re­
duced secretion of active ­mating factor in cells that lack 
either BTN1 (Fig. S1 D) or BTN2 (Kanneganti et al., 2011), we 
examined whether a similar effect was apparent in yck3 cells. 
We found that halo formation induced by the yck3 cells was 
also reduced relative to WT cells (Fig. S1 D). Overall, the re­
sults suggest that the deletion of YCK3 phenocopies that of 
either BTN1 or BTN2. We also examined Yif1 and Kex2 local­
ization in btn1yck3 cells but did not discern significant dif­
ferences in relation to the single mutants, nor were defects in 
growth observed (unpublished data). This suggests that BTN1 
and YCK3 are probably epistatic.
As Yck3 is involved in protein uptake to the vacuole via 
the AP­3 pathway and not via the clathrin­ and endosome­ 
dependent AP­2 route that Yif1 likely takes, we examined 
whether the AP­3 pathway is affected in btn1 cells. To do this, 
Figure 4.  BTN1 overexpression or deletion has opposing effects on Golgi 
morphology. (A) Deletion of BTN1 enhances Golgi clustering in cells ex-
pressing GFP-Sed5. WT, btn1, and WT cells overexpressing BTN1 from 
a multicopy plasmid (BTN1) and all expressing GFP-Sed5 from a single-
copy plasmid are shown. Note the large puncta in btn1 cells. (B) Dele-
tion of BTN1 enhances Golgi clustering in cells expressing GFP-Sed5
317A, 
whereas BTN1 overexpression enhances fragmentation (same as in A, 
except all strains express GFP-Sed5
317A). Note the large puncta in WT 
and btn1 cells. (C) Golgi clustering is reduced in btn1 cells express-
ing GFP-Sed5
317D (same as in A, except all strains express GFP-Sed5
317D).   
(D) Deletion of BTN1 enhances Golgi clustering in cells expressing GFP-Sed5 
from its genomic locus (GFP-Sed5 integrated [int.]). WT, btn1, and WT 
cells overexpressing BTN1 from a multicopy plasmid (BTN1) and all ex-
pressing GFP-SED5 from its genomic locus are shown. Note the larger 
puncta in btn1 cells. (E) BTN1 overexpression reduces Golgi clustering in 
cells expressing GFP-Sed5
317A from its genomic locus (same as in D, except 
all cells express GFP-SED5
317A). Note the reduction in puncta size in cells 
overproducing Btn1. (F) Deletion of BTN1 enhances Golgi clustering in 
cells expressing GFP-Sed5
317D from its genomic locus (same as in D, except 
all cells express GFP-SED5
317D). Note the enhancement in puncta size in 
cells lacking BTN1. Bars, 1 µm.209 Btn1 regulates endosome–Golgi retrograde transport • Kama et al.
we expressed a GFP­tagged Nyv1­Snc1 fusion protein that local­
izes to the vacuole­limiting membrane in WT cells but is partly 
mislocalized to the plasma membrane in cells lacking an AP­3 
component  (e.g.,  apl5).  We  examined  GFP–Nyv1­Snc1  in 
btn1 cells and found no mislocalization, unlike in apl5 or 
yck3 cells (Fig. S3 A). Thus, the AP­3 pathway appears intact 
in cells lacking BTN1. In addition, we examined localization of 
GFP­tagged Apl5 expressed from its chromosomal locus in cells 
lacking BTN1 but saw no difference with WT cells (Fig. S3 B).
Because the deletion of BTN1 leads to enhanced Golgi 
clustering (Fig. 4), we examined the effect of the deletion of 
YCK3  in WT  cells  and  btn1  cells  expressing  GFP­Sed5 
(Fig. 5, E and F). In both yck3 (Fig. 5 E and Table S4) and 
yck3btn1 cells, Sed5 labeled large puncta that did not colabel 
with RFP­Vps27 or FM4­64 (Fig. 5 F), indicating that these 
are not endosomal compartments. Thus, the loss of Btn1 (Figs. 4 
and 5 E and Table S4), Yck3 (Fig. 5 E and Table S4), or both 
(Fig. 5 F) results in enlargement of the Golgi.
Btn1 may control Yck3 phosphorylation  
of Sed5
With the exception of its necessity for AP­3–dependent protein 
sorting, the deletion of YCK3 parallels that of BTN1. Thus, Yck3 
could act downstream of Btn1 and phosphorylate Sed5. To test 
this hypothesis, we examined Sed5 phosphorylation in cells 
lacking YCK3; however, no significant change in Sed5 phos­
phorylation was observed therein (unpublished data). Thus, either 
Yck3 does not phosphorylate Sed5 or, because Yck3 and Hrr25 
form an essential pair (Wang et al., 1996), then Hrr25 (or the 
other Yck kinases, e.g., Yck1 and Yck2) substitutes for Yck3 in 
the constitutive yck3 deletion background. To test the latter 
possibility, we created an inducible form of YCK3 whose ex­
pression from its chromosomal locus is under the control of 
the GAL1 promoter. When cells were grown continually in the 
presence of galactose, both the NP and P forms of Sed5 were 
Figure 5.  BTN1 overexpression and deletion have opposing effects on 
Sed5 phosphorylation. (A) Sed5 is underphosphorylated in cells lacking 
BTN1 or YCK3. (left) WT cells, WT cells overexpressing BTN1 from a multi-
copy plasmid (BTN1), and btn1 cells were grown on glucose-containing 
medium. In parallel, cells expressing SED5 under a galactose-inducible 
promoter (GAL-SED5) were grown on galactose-containing medium and 
were shifted to glucose-containing medium for 16 h (to yield the sed5 
condition). Cells were processed for Western analysis and probed with 
anti-Sso antibodies to detect Sso1/2 (as a loading control), whereas anti-
Sed5 antibodies were used to detect Sed5. NP indicates the lower mo-
lecular mass/NP form of Sed5, whereas P indicates the higher molecular 
mass/P form. The histogram shows quantification (in arbitrary units) of 
the upper (P) and lower bands (NP) of Sed5 after normalization for Sso 
loading. (right) Cells expressing YCK3 under a GAL promoter (GAL-YCK3) 
were grown on galactose-containing medium and were shifted to glucose- 
containing medium for 8 h (to yield the yck3 condition) or were maintained 
on galactose-containing medium as a control. In parallel, cells expressing 
SED5 under a galactose-inducible promoter (GAL-SED5) were grown on 
galactose-containing medium and were shifted to glucose-containing me-
dium for 16 h (to yield the sed5 condition). Cells were processed for 
Western analysis, and both Sed5 and Sso were detected as previously de-
scribed. Note the presence of only the NP form of Sed5 (NP) in btn1 cells 
and in GAL-YCK3–expressing cells grown on glucose-containing medium. 
Also, note lack of Sed5 in GAL-SED5 cells grown on glucose-containing 
medium. The histogram shows quantification of the upper (P) and lower 
bands (NP) after normalization. The data shown are representative of mul-
tiple replicates of the experiment (n = 4). (B) Yif1 is mislocalized in the ab-
sence of Yck3. Yeast lacking YCK3 (yck3) and expressing GFP-Yif1 from 
a single-copy plasmid were labeled with FM4-64. The top row depicts an 
endosomal pattern of labeling, whereas the bottom row depicts endosomal 
and vacuolar labeling. (C) Yif1 is localized to LEs in cells lacking YCK3. 
yck3 cells expressing GFP-Yif1 and RFP-Vps27 from single-copy plasmids 
are shown. (D) Kex2 is mislocalized in the absence of Yck3. yck3 yeast 
expressing Kex2-GFP from a single-copy plasmid and labeled with FM4-64 
are shown. (E) The deletion of YCK3 enhances Golgi size. WT, btn1, 
and yck3 cells expressing GFP-Sed5 and RFP-Vps27 from single-copy 
plasmids are shown. Note that the GFP-Sed5 and RFP-Vps27 signals do 
not overlap. (F) The double deletion of BTN1 and YCK3 does not further 
enhance Golgi size. btn1yck3 cells expressing GFP-Sed5 from a single-
copy plasmid are shown. Bars, 1 µm.
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observed in Western blots (NP/P ratio = 3:1; Fig. 5 A, right). 
However, only the NP form of Sed5 was apparent in cells shifted 
to glucose for 8 h (NP/P ratio = 7:1; Fig. 5 A, top and bottom 
right). Thus, the turn­off of YCK3 results in a significant de­
crease in Sed5 phosphorylation. This suggests that either Yck3 
phosphorylates Sed5 directly or that its activation is necessary 
for Sed5 phosphorylation by another kinase.
One means by which Btn1 might regulate Yck3 is by con­
trolling its localization. Yck3 is mainly found on the vacuolar 
membrane, although endosome­ and plasma membrane–localized 
Yck3 is functional (Sun et al., 2004; Cabrera et al., 2010), and 
the protein likely undergoes palmitoylation early in the secre­
tory pathway (e.g., ER and Golgi) where the DHHC class of 
palmitoyl transferases is found (Ohno et al., 2006). We exam­
ined the localization of GFP­tagged Yck3 expressed from its 
chromosomal locus in cells lacking BTN1 and found that it la­
beled the limiting membrane of the vacuole and plasma mem­
brane in both WT and btn1 cells (Fig. S4 A). Thus, Btn1 does 
not appear to regulate Yck3 localization.
Substitution of the Yck3 lipid anchor 
with a TMD bypasses the requirement for 
palmitoylation or Btn1 in LE–Golgi retrieval
Because Yck3 palmitoylation is essential for its function, we 
examined whether mutations in the DHHC palmitoyl transfer­
ases affect LE–Golgi sorting (Fig. 6, A and B). The deletion of 
individual palmitoyltransferase genes, such as AKR1, a Golgi 
protein that palmitoylates Yck kinases (Sun et al., 2004), or 
PFA3, a vacuolar transferase that palmitoylates Vac8 and other 
substrates (Hou et al., 2005, 2009), had no effect on Yif or Kex2 
localization (unpublished data). However, we found that both 
Yif1 and Kex2 were completely mislocalized in cells lacking 
five of the seven yeast DHHC transferases (i.e., DHHC 5× 
cells; Fig. 6 A and Tables S5 and S2, respectively), which are 
known to mislocalize Yck3 (Hou et al., 2009). Moreover, we 
could verify that GFP­Yck3 did not show vacuolar, but rather 
endosome­like labeling, in these cells (Fig. 6 B). Thus, selective 
LE–Golgi protein retrieval is sensitive to changes in DHHC 
levels, indicating that the palmitoylation of substrates, such as 
Yck3, is likely to be involved. It is noteworthy to add that the 
Figure 6.  Yck3 palmitoylation is required for LE–Golgi sorting but can be 
obviated upon substitution with a TMD. (A) Palmitoyltransferase activity is 
required for LE–Golgi retrieval. Yeast lacking five DHHC palmitoyltrans-
ferases (DHHC 5×) and expressing either GFP-YIF1 (top) or KEX2-GFP 
(bottom) are shown. Note the localization of Yif1 to LE and vacuole and 
Kex2 to the vacuole membrane. (B) Yck3 is mislocalized to LEs in cells 
depleted of palmitoyltransferases. DHHC 5× yeast expressing GFP-YCK3 
are shown. (C) Depletion of DHHC palmitoyl transferases reduces Sed5 
phosphorylation. WT, btn1, and DHHC 5× cells were processed for   
Western  analysis  with  anti-Sed5  and  -Sso  antibodies,  as  described  in   
Fig. 5 A. NP and P indicate the NP and P form of Sed5, respectively. The histo-
gram shows quantification of the Sed5 bands after normalization. The data 
shown are representative of multiple replicates of the experiment (n = 3). 
(D) Yif1 is mislocalized to LEs in yck3 cells expressing a Yck3-FYVE fusion 
protein. WT and btn1 cells expressing both YCK3-FYVE from the YCK3 
locus and GFP-YIF1 from a single-copy plasmid are shown. (E) Expression 
of Yck3 fused to a TMD bypasses the Btn1 requirement for Yif1 localiza-
tion to the Golgi. btn1 cells and btn1 cells expressing YCK3-VAM3 from 
the YCK3 locus were transformed with a plasmid expressing GFP-Yif1, 
labeled with FM4-64, and examined. Note the localization of Yif1 to LEs 
in btn1 cells and to smaller puncta (that do not colabel with FM4-64) in 
cells expressing Yck3-Vam3. (F) Expression of Yck3-Vam3 partially restores 
Sed phosphorylation. WT, btn1, and btn1 cells expressing YCK3-VAM3 
were processed for Western analysis and Sed5 quantification, as described 
in Fig. 5 A. The data shown are representative of multiple replicates of the 
experiment (n = 2). Bars, 1 µm.
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btn1 cells (in this representative experiment), and no signifi­
cant effect upon the overall levels of Sed5 protein was observed 
in the btn2 cells. Next, we examined Golgi morphology in 
WT, btn1, and btn2 cells expressing either GFP­Sed5 or 
GFP­Sed5
317A. We found that the deletion of BTN2 had similar 
effects as the deletion of BTN1; namely, an increase in Golgi 
clustering was observed in btn2 cells expressing GFP­Sed5 
(Fig. S5 B and Table S6). In contrast, BTN2 overexpression or 
deletion had little effect on Golgi clusters formed in the pres­
ence of GFP­Sed5
317A (Fig. S5 C and Table S6). This indicates 
that Btn2 overproduction does not block Golgi clustering, which 
is in contrast to BTN1 overexpression (Fig. 4 B). Overall, the 
removal of BTN2 results in changes in Sed5 phosphorylation 
and Golgi morphology that are similar to the deletion of BTN1. 
Although this could indicate that Btn1 and Btn2 confer like 
functions, it is more probable that the removal of BTN2 results 
in Btn1 mislocalization to the vacuole (as shown in Fig. 2 D), 
hence resulting in a loss of function.
Discussion
We previously demonstrated that BTN2, a gene up­regulated in 
the absence of BTN1, encodes a component of a transport com­
plex that retrieves specific proteins back to the Golgi (Kama   
et al., 2007). We now show that in the absence of BTN1, Golgi 
proteins like Yif1 and TGN­EE proteins like Kex2 fail to re­
trieve to the Golgi and accumulate in late compartments of the 
endosomal pathway (Fig. 1 and Tables S1 and S2). This is indi­
cated  by  the  colocalization  of Yif1  and  Kex2  with  FM4­64   
and/or Vps27 in cells lacking BTN1 (Fig. 1). This phenotype 
shared between btn1 and btn2 cells implies common defects   
in the sorting of material away from the vacuole to the Golgi. 
Thus, defects in LE–Golgi protein recycling may contribute to 
the mechanism underlying Batten Disease/NCL pathogenesis.
Yeast Btn1 and mammalian CLN3 are membrane proteins 
of unclear function, and, although a wide range of localization 
patterns and actions have been attributed to them, recent studies 
from S. cerevisiae (Vitiello et al., 2010), S. pombe (Codlin and 
Mole, 2009), and mammalian cells (Metcalf et al., 2008) imply 
that Golgi localization and/or function may be involved. We 
find that S. cerevisiae Btn1 expressed from its chromosomal   
locus or from single­copy plasmids localizes to Golgi structures 
(Fig. 2 A) that colabel with either Yif1 or Sec7 (Fig. 2 B). Thus, 
although Btn1 and Btn2 have distinct patterns of localization 
(i.e., Btn2 localizes to LEs; Kama et al., 2007), both contribute 
to the same transport process. However, Btn1 probably acts in a 
different manner than Btn2, which binds to retrieval factors like 
retromer, endosomal SNAREs, Snx4, and even to Yif1 (Kama   
et al., 2007). Studies made with cultured mammalian cells or 
fission yeast suggest that CLN3 and btn1 act in an unknown 
fashion upon protein export from the Golgi and mislocalize   
the mannose­6­phosphate receptor or its S. pombe equivalent, 
vps10, respectively, to varying degrees (Metcalf et al., 2008; 
Codlin and Mole, 2009). In contrast, Vps10 and CPY trafficking 
is normal in btn1 cells (Fig. S1, A and B), as observed for 
btn2 cells (Kama et al., 2007; Kanneganti et al., 2011). This 
suggests that the Vps10–CPY sorting pathway of S. cerevisiae 
overexpression of BTN1 did not restore Yif1 or Kex2 Golgi local­
ization in DHHC 5× cells (unpublished data), which suggests 
that Btn1 probably does not enhance Yck3 palmitoylation via 
the remaining acyltransferases. Lastly, we examined whether 
Sed5 undergoes phosphorylation in the DHHC 5× cells by 
Western analysis (Fig. 6 C, top and bottom). We found that 
levels of the P form of Sed5 were greatly reduced in btn1 cells 
(NP/P ratio = 6:1 in btn1 cells vs. 2:1 in WT cells), as shown 
in Fig. 5 A. In the DHHC 5× cells, the NP/P ratio remained at 
6:1 (5.8 ± 0.3; n = 2), although the levels of Sed5 protein were 
similar to those seen in WT cells. Thus, removal of the DHHC 
transferases inhibits both selective LE–Golgi retrieval and 
Sed5 phosphorylation.
If Btn1 is a palmitoyl protein desaturase and thus a poten­
tial regulator of palmitoylated proteins as suggested for CLN3 
(Narayan et al., 2006, 2008) and LE–Golgi retrieval as sug­
gested here, then substitution of the cysteine­rich palmitoylated 
domain in Yck3 with either an endosome localization sequence 
(e.g., FYVE domain) or a TMD could render it functional and 
restore LE–Golgi retrieval in cells lacking Btn1. Therefore, we 
deleted BTN1 in cells expressing Yck3­FYVE (Cabrera et al., 
2010) or Yck3 bearing the Vam3 TMD (which fully supports 
Vps41 phosphorylation and vacuolar protein sorting; unpub­
lished data) and examined the localization of GFP­Yif1 therein 
(Fig. 6, D and E). We found that Yif1 mislocalized to LEs in the 
btn1 control and btn1 YCK3-FYVE cells but not in btn1 
YCK3-VAM3 cells (Fig. 6 [D and E] and Table S5). Yif1 local­
ization in the btn1 YCK3-VAM3 cells did not colabel with 
FM4­64 and appeared Golgi­like. This indicates that addition of 
a TMD (which confers transport through the secretory pathway) 
to Yck3 is sufficient to bypass (at least in part) the requirement 
for Btn1 in selective LE–Golgi sorting. Furthermore, this result 
implies that Btn1 may affect the lipid anchor of Yck3 in some 
manner and thus regulate protein function.
We then examined whether Sed5 phosphorylation is re­
stored in btn1 YCK3-VAM3 cells and found that the ratio of 
NP to P Sed5 was 4.5 ± 0.2:1 (n = 2; see representative experi­
ment in Fig. 6 F, top and bottom). This result was intermediate 
to that of WT cells, which gave an average ± SD ratio of 2.1 ± 0.1:1 
(n = 4), and btn1 cells, which had an average of 7.2 ± 1.7:1   
(n = 4). Thus, substitution of the Yck3 acyl anchor with a TMD 
not only appears to restore Yif1 trafficking but may confer the 
ability of Sed5 to undergo modification.
Sed5 phosphorylation and Golgi morphology   
are affected in part by the deletion  
of BTN2
Because the deletion of BTN1 largely phenocopies that of BTN2 
with respect to protein trafficking (i.e., Yif1 and Kex2 mislocal­
ization and normal Vps10 and CPY localization; Figs. 1 [A and C]  
and S1 [A, B, and D]; Kama et al., 2007), we examined whether 
the deletion of BTN2 has parallel effects upon Sed5 phosphory­
lation and Golgi morphology as that of BTN1. First, we exam­
ined Sed5 phosphorylation in WT, btn1, and btn2 cells and 
observed a robust reduction in the P form relative to the NP 
form (e.g., NP/P ratio = 6.5:1) in cells lacking BTN2 (Fig. S5 A). 
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control of Sed5 and LE–Golgi sorting by Btn1 and Yck3 is 
shown in Fig. 7.
How  Btn1  actually  regulates Yck3  function  is  unclear; 
however, it might occur via regulation of the lipid anchor moiety. 
This conjecture is supported by the fact that substitution of the 
palmitate acceptor region in Yck3 with a TMD allows yeast to 
bypass the Btn1 requirement in LE–Golgi sorting (Fig. 6 E and 
Table S5) and partially restores Sed5 phosphorylation (Fig. 6 F). 
Yck3 palmitoylation and membrane anchoring are required for 
normal vacuolar fusion (Hou et al., 2009) as well as its function 
in LE–Golgi sorting, the latter being indicated by the fact that 
Yif1 and Kex2 are missorted in cells lacking five of the DHHC 
class of palmitoyl transferases (Fig. 6 A and Tables S2 and S5) 
and that Sed5 is underphosphorylated therein (Fig. 6 C). Al­
though we have not proven whether Btn1 (or CLN3) is a palmi­
toyl  protein  desaturase,  it  does  show  that  modulation  of  the 
palmitate anchor could play an important role in kinase function 
in yeast and, potentially, could form the basis for disease onset in 
postmitotic cells (e.g., neurons) lacking an inherent ability to   
either control or turn over palmitoylated proteins in a proper 
fashion. In this regard, it is highly interesting and probably not 
coincidental that the infantile form of NCL occurs as a result of 
mutation in a lysosomal palmitoyl thioesterase, although the 
target substrates for this enzyme have yet to be identified (Vesa 
et al., 1995; Mole et al., 2005; Siintola et al., 2006; Getty and 
Pearce, 2011). If, as in yeast, mammalian CLN3 controls a se­
cretory kinase, screens for regulators of kinase function may 
identify therapeutic agents of benefit to Batten disease patients.
Materials and methods
Media, DNA, and genetic manipulations
Yeast were grown to midlog phase at 26°C in standard growth media con-
taining either 2% glucose or 3.5% galactose. Synthetic complete and drop-
out  media  were  prepared  as  previously  described  (Haim-Vilmovsky  and 
differs from that of S. pombe. This difference may relate to the 
finding that both Btn2 and Vps10 colocalize with Vps27 but do 
not colocalize with each other (Kama et al., 2007), indicating 
that there may be different LE populations in budding yeast.
Despite differences in Vps10–CPY trafficking, our results 
suggest  that  S.  cerevisiae  Btn1  controls  protein  trafficking 
within the Golgi. BTN1 overexpression inhibited Ykt6, an   
R­SNARE that confers intra­Golgi protein sorting and protein 
trafficking into and out of the Golgi, from assembling into a   
canonical 1R–3Q complex with an essential Golgi Q­SNARE, 
Sed5, and two additional Q­SNAREs implicated in endosome–
Golgi trafficking, Vti1 and Tlg1 (Fig. 3 A). Likewise, the over­
expression or deletion of BTN1 had opposing effects on the 
ability of Sed5 to assemble into multiple SNARE complexes 
(Fig. 3 B) as well as to maintain Golgi morphology (Fig. 4 and 
Tables S3 and S4). Importantly, Btn1 regulates the phosphory­
lation state of Sed5, which was shown to control retrograde pro­
tein trafficking from the Golgi as well as Golgi morphology 
(Weinberger et al., 2005). In the absence of BTN1, Sed5 is in an 
underphosphorylated state (Figs. 5 A, 6 (C and F), and S5 A) 
that mimics the NP form and results in an enhancement of Golgi 
clustering  (Fig.  4  (A–F)  and  Table  S3)  and  an  increase  in 
SNARE assembly (Fig. 3 B). In contrast, BTN1 overexpression 
mimicked the constitutively P form of Sed5 by dispersing Golgi 
clusters (e.g., those formed by Sed5
317A; Figs. 4 (B and E) and 
Table S3), reducing SNARE assembly (Fig. 3 B), and inhibiting 
the growth of cells bearing mutant SNAREs involved in Golgi 
trafficking (Fig. S2). Finally, BTN1 overexpression may even 
enhance Sed5 modification slightly (Fig. 5 A). Thus, it appears 
that Btn1 regulates Sed5 phosphorylation and, therefore, func­
tion. Importantly, we noted that the deletion of BTN2 also had 
effects on Sed5 phosphorylation and Golgi morphology (Fig. S5); 
however, these could result from the mislocalization of Btn1 
that occurs in btn2 cells (Fig. 2 D).
Because Btn1 is not a kinase, it must be indirectly in­
volved in Sed5 phosphorylation. Two pieces of evidence sug­
gested that Yck3 might be involved. First, mammalian CLN3 
was suggested to function as a palmitoyl protein desaturase 
(Narayan et al., 2006, 2008). Second, Yck3 is a palmitoylated 
endosome­ and vacuole­associated casein kinase involved in 
protein sorting to the vacuole (Sun et al., 2004; LaGrassa and 
Ungermann, 2005). Moreover, although Yck3 shares essential 
functions with a paralog, Hrr25 (Wang et al., 1996), and is able 
to suppress deletions in homologues that function primarily at 
the plasma membrane (e.g., Yck1 and Yck2; Sun et al., 2004), it 
also phosphorylates proteins involved in vacuole protein trans­
port, such as Vps41 and Vam3 (LaGrassa and Ungermann, 
2005; Brett et al., 2008). We examined Sed5 phosphorylation in 
cells expressing an inducible form of YCK3 and found that this 
t­SNARE was underphosphorylated after the turn­off of expres­
sion (Fig. 5 A, right). Thus, Yck3 is a candidate kinase for Sed5 
phosphorylation. Moreover, the deletion of YCK3 resulted in 
strong defects in LE–Golgi sorting (Fig. 5, B–D), which paral­
lel those seen in btn1 and btn2 cells (Fig. 1 and Tables S1 
and S2). This strengthens the idea that Yck3 is involved with 
Btn1 function, although Sed5 may not be the only substrate   
involved in the regulation of LE–Golgi sorting. A model for the 
Figure 7.  A model for the control of Sed5 phosphorylation and LE–Golgi 
transport by Btn1 and Yck3. Yif1 is in the trans-Golgi in WT cells but 
delocalizes to the LE in cells lacking either BTN1 or YCK3. Thus, Btn1 
and Yck3 mediate Yif1 retrieval. Sed5 is a Golgi SNARE that undergoes 
a phosphorylation/dephosphorylation cycle important for its localization 
and function (Weinberger et al., 2005). Btn1 regulates Yck3 kinase func-
tion, resulting in Sed5 phosphorylation either directly by Yck3 (as shown) 
or indirectly through another kinase (not depicted). Sed5 phosphorylation 
and dephosphorylation alter SNARE assembly in a manner that regulates 
retrograde transport, resulting in the retrieval of Yif1 to the Golgi. The 
phosphatase that dephosphorylates Sed5 is unknown but whose function 
must be coordinated with Yck3 to control SNARE assembly.213 Btn1 regulates endosome–Golgi retrograde transport • Kama et al.
TE containing 1% NP-40 (volume/volume), 10 µg/ml aprotinin, 10 µg/ml 
leupeptin, 10 µg/ml soybean trypsin inhibitor, 10 µg/ml pepstatin, and 
100 µM PMSF. For the detection of P Sed5 in Western blots, the lysis buffer 
was supplemented with the following phosphatase inhibitors: 10 mM NaF, 
20 mM NaPPi, 25 mM -glycerophosphate, and 0.5 mM sodium vana-
date. For IP experiments, 15 OD600 units of cells were used for each pull-
down. Cell extracts were prepared by adding an equal volume of washed 
glass beads (e.g., 0.25 ml) to the cells followed by prolonged shaking at 
2,200 rpm in a Vibrax shaker (IKA Laboratories Ltd.) at 4°C for 45 min. 
Extracts were clarified by centrifugation at 12,000 g for 10 min to yield total 
cell lysates (TCLs). Protein concentration was determined using the Pierce 
MicroBCA protein assay kit (Thermo Fisher Scientific). For each IP reaction, 
0.5 mg of TCL was diluted with ice-cold IP buffer (1% NP-40 in TE) to a final 
volume of 0.5 ml and was incubated with the appropriate IP antibody (see 
below). IP was performed at 4°C with constant rotation for 16 h, and pre-
cipitation of the complexes was performed by adding a 30-µl bed volume 
of protein G–agarose (Santa Cruz Biotechnology, Inc.) prewashed in IP 
buffer to the IP mixture. After 2 h of incubation with constant rotation, the 
complexes were spun down and washed three times with ice-cold IP wash 
buffer (TE containing 1% NP-40 and 150 mM NaCl). Precipitated proteins 
were resuspended in 30 µl SDS-PAGE sample buffer and boiled (3 min) 
before electrophoresis on 10 and 12.5% polyacrylamide gels (i.e., low mo-
lecular mass proteins <60 kD were resolved on 12.5% gels, whereas high 
molecular mass proteins >60 kD were resolved in parallel on 10% gels). 
Where relevant, samples of TCLs (e.g., 30 µg of protein per lane) were 
electrophoresed in parallel to the IP samples. For immunoblotting, gels 
were electroblotted onto pure nitrocellulose blotting membranes (BioTrace; 
Pall Corporation). Blots were blocked with 5% nonfat milk in TBS (PBS solu-
tion containing 0.05% Tween 20) and then probed with the appropriate 
antibody in TBS containing 5% BSA and 3 mM NaN3. Protein expression 
was detected by an ECL detection kit (GE Healthcare).
Affinity-purified IP antibodies included monoclonal anti-myc (9E10, 
3 µl per IP; Santa Cruz Biotechnology, Inc.) and anti-HA antibodies (16B12, 
2.5 µl per IP; Covance). Antibodies for protein detection in Western blots 
or  on  nitrocellulose  filters  included  polyclonal  antibodies  against  Bet1   
(diluted 1:1,000; provided by C. Barlowe, Dartmouth College, Hanover, 
NH); CPY (a gift from S. Emr, University of California, San Diego, La Jolla, 
CA); Gos1, Sft1, and Ykt6 (diluted 1:1,000; gifts from D. Banfield); Sed5 
(diluted 1:3,000; a gift from H. Pelham, Medical Research Council, Cam-
bridge, England, UK); Snc1 (diluted 1:500; Protopopov et al., 1993); 
Sso1/2 (diluted 1:1,000; a gift from S. Keranen, Technical Research Centre 
of Finland, Espoo, Finland); Tlg1 (diluted 1:3,000; a gift from H. Pelham); 
Tlg2 (diluted 1:750; a gift from H. Abeliovich, Hebrew University of Jerusalem, 
Rehovot, Israel); Vti1 (diluted 1:1,000; a gift from G. Fischer von Mollard, 
University of Göttingen, Göttingen, Germany); and monoclonal antibodies 
to the HA and myc epitopes (diluted 1:1,000).
To distinguish between the higher and lower molecular mass forms 
of Sed5 (i.e., upper and lower bands), TCL samples were subjected to   
SDS-PAGE on 11.5% acrylamide gels. Quantification of the upper (i.e., P) and 
lower (i.e., NP) bands of Sed5 in Western blots by density measurement was 
performed using ImageJ software (National Institutes of Health). Molecular 
mass markers are listed in kilodaltons for all Western blots.
Online supplemental material
Fig. S1 demonstrates that the deletion or overexpression of BTN1 does not 
alter localization of a wide variety of endosome-trafficked proteins. Fig. S2 
shows that the deletion and overexpression of BTN1 have opposing effects 
on the growth of temperature-sensitive mutants of Golgi SNAREs. Fig. S3 
shows that the deletion of BTN1 does not affect AP3-mediated protein 
sorting or localization of an AP-3 component. Fig. S4 shows that Yck3 is 
not mislocalized in btn1 cells, although YCK3 overexpression inhibits the 
growth of Golgi SNARE mutants. Fig. S5 shows that the deletion of BTN2  
also affects Sed5 phosphorylation and Golgi morphology. Table S1 pro-
vides statistics for the localization of GFP-Yif1 in btn1 and yck3 cells.   
Table S2 provides statistics for the localization of Kex2-GFP in btn1, yck3, 
and DHHC 5× cells. Table S3 provides statistics for the localization of 
GFP-Sed5 in WT cells lacking or overexpressing BTN1. Table S4 provides 
statistics for the localization of GFP-Sed5 in yck3 cells. Table S5 provides 
statistics for the localization of GFP-Yif1 in cells expressing mutant Yck3   
proteins or lacking DHHC palmitoyl transferases. Table S6 provides sta-
tistics for the localization of GFP-Sed5 in cells lacking or overexpressing 
BTN2. Table S7 includes the yeast strains used in this study, and Table 
S8 includes the plasmids used for this study. Finally, Table S9 provides 
a  glossary  describing  the  genes  used  in  this  study.  Online  supple-
mental material is available at http://www.jcb.org/cgi/content/full/ 
jcb.201102115/DC1.
Gerst, 2009), whereas rich growth medium (yeast extract peptone dextrose) 
and an amino acid–enriched synthetic complete medium were prepared ac-
cording to Rose et al. (1990). Standard methods were used for the introduc-
tion of DNA into yeast and the preparation of genomic DNA (Rose et al., 
1990). The tagging of genes at their genomic loci with GFP or deletion of 
genes was performed by homologous recombination using PCR products 
with flanking regions to the appropriate genomic sequences generated using 
specific primers to genome-tagging plasmids used as templates (Longtine   
et al., 1998).
Growth tests
For growth tests on plates, yeast were grown to log phase, normalized for 
optical density (OD600), diluted serially (i.e., 10-fold), and plated by drops 
onto solid medium preincubated at different temperatures.
Halo assays
Halo assays for measuring the production of biologically active -factor were 
performed by spotting MAT- yeast strains onto a lawn of MATa sst2 indica-
tor yeast, as previously performed (Kanneganti et al., 2011). Assays were 
performed in triplicate.
Yeast strains and plasmids
The  yeast  strains  used  are  listed  in  Table  S7.  T.  Lagrassa  (University  of   
Osnabrück, Osnabrück, Germany) provided the the YCK3-VAM3 strain. The 
plasmids used in this study are listed in Table S8. To create a plasmid express-
ing HA-tagged Ykt6-1 (including its 3 untranslated region [UTR], which could 
be used as a temperature-sensitive tool for use in immunoprecipitation [IP]   
assays), the ykt6-1 gene (Ykt6 bearing substitutions S35G, L125G, D149G, 
S182R, and M185T; a gift from D. Banfield, Hong Kong University of Sci-
ence and Technology, Hong Kong, China) was amplified by PCR using the 
isolated balancer plasmid recovered from the SARY 166 strain as a template 
and primers encoding SalI and SacI sites for amplification at the 5 and 3 
ends, respectively. The SalI–SacI fragment was inserted in-frame and down-
stream to the myc epitope encoded in vector pRS313 (CEN and URA3). To 
create a yeast expression plasmid for CLN3, the human CLN3 gene was   
amplified by PCR using cDNA derived from HeLa cells as a template and 
primers encoding SalI and SacI sites for amplification at the 5 and 3 ends, 
respectively. The SalI–SacI fragment was inserted in-frame and downstream 
to the HA epitope encoded by vector pAD54 (2 and LEU2). A construct for 
the integration of GFP-tagged BTN1 at its genomic locus was created by sub-
cloning an SalI and BglII fragment bearing GFP-BTN1-3UTR from plasmid 
pUG46-GFP-BTN1(+3 UTR) into plasmid pFA6a–natMX4, which encodes a 
PCR amplification module for integration at target genes using selection for 
resistance to nourseothricin via the SalI and BglII sites. After verification by 
sequencing, an integration cassette containing GFP-BTN1-3UTR-natMX-BTN1 
was amplified using a 60-bp forward chimeric oligonucleotide correspond-
ing to the 5 UTR of BTN1 and GFP (which follows directly downstream) and 
a  60-bp  reverse  chimeric  oligonucleotide  corresponding  to  the  pFA6a- 
nat-MX4 plasmid (after the nat gene sequence) and a region of the 3 UTR of 
BTN1 beginning 210 bp after the stop codon. Fragments obtained by PCR 
amplification were used to transform WT yeast and were selected for me-
dium containing clonNAT (nourseothricin; CAS no. 96736-11-7; WERNER 
BioAgents). Integration at the BTN1 locus was verified by PCR.
Microscopy
GFP and RFP fluorescence in strains expressing the appropriate GFP- and 
RFP-tagged fusion proteins/FM4-64 fluorescence, respectively, was visual-
ized by confocal microscopy. Unless mentioned, cells were grown to mid-
log phase at 26°C in synthetic selective medium before visualization. For 
vacuolar staining, cells were pulsed with 5.4 µM FM4-64 (Invitrogen) for 
30 min in the dark at 26°C. After the pulse, a chase of 20 min in the same 
medium lacking FM4-64 was performed. In the figures, merge indicates   
either merger of the GFP and FM4-64 panels or GFP and RFP panels where 
appropriate. Light indicates the differential interference contrast (DIC) 
panel. All bars equal 1 µm. Images were captured with a confocal imaging 
system (LSM 710; Carl Zeiss) mounted on an inverted microscope (Axio-
Observer; Carl Zeiss) using a Plan Apochromat 63×/1.40 N.A. objective. 
Image acquisition was accomplished at 26°C using the detection system 
and accompanying software provided by the manufacturer. Photoshop 
(Adobe) was used to assemble and size the images for figure preparation.
IP and Western analysis
Cell lysates for use in IP experiments and immunoblots were prepared using 
glass beads to break intact cells. Cells were grown to midlog phase at 
26°C before harvesting, washed with TE (10 mM Tris-Hcl, pH 7.5, and   
1 mM EDTA), and resuspended in 250–300 µl of lysis buffer consisting of JCB • VOLUME 195 • NUMBER 2 • 2011   214
CLN3, regulates vacuole homeostasis. J. Cell Sci. 118:5525–5536. http://
dx.doi.org/10.1242/jcs.02656
Getty, A.L., and D.A. Pearce. 2011. Interactions of the proteins of neuronal ce­
roid lipofuscinosis: Clues to function. Cell. Mol. Life Sci. 68:453–474. 
http://dx.doi.org/10.1007/s00018­010­0468­6
Gurunathan, S., D. Chapman­Shimshoni, S. Trajkovic, and J.E. Gerst. 2000. Yeast 
exocytic v­SNAREs confer endocytosis. Mol. Biol. Cell. 11:3629–3643.
Haim­Vilmovsky, L., and J.E. Gerst. 2009. m­TAG: a PCR­based genomic in­
tegration  method  to  visualize  the  localization  of  specific  endogenous 
mRNAs in vivo in yeast. Nat. Protoc. 4:1274–1284. http://dx.doi.org/10 
.1038/nprot.2009.115
Hettema, E.H., M.J. Lewis, M.W. Black, and H.R. Pelham. 2003. Retromer 
and the sorting nexins Snx4/41/42 mediate distinct retrieval pathways 
from  yeast  endosomes.  EMBO  J.  22:548–557.  http://dx.doi.org/10.1093/ 
emboj/cdg062
Holthuis, J.C., B.J. Nichols, S. Dhruvakumar, and H.R. Pelham. 1998. Two 
syntaxin homologues in the TGN/endosomal system of yeast. EMBO J. 
17:113–126. http://dx.doi.org/10.1093/emboj/17.1.113
Hou, H., K. Subramanian, T.J. LaGrassa, D. Markgraf, L.E. Dietrich, J. Urban, N. 
Decker, and C. Ungermann. 2005. The DHHC protein Pfa3 affects vacuole­
associated palmitoylation of the fusion factor Vac8. Proc. Natl. Acad. Sci. 
USA. 102:17366–17371. http://dx.doi.org/10.1073/pnas.0508885102
Hou, H., A.T. John Peter, C. Meiringer, K. Subramanian, and C. Ungermann. 
2009. Analysis of DHHC acyltransferases implies overlapping substrate 
specificity and a two­step reaction mechanism. Traffic. 10:1061–1073. 
http://dx.doi.org/10.1111/j.1600­0854.2009.00925.x
Kaganovich, D., R. Kopito, and J. Frydman. 2008. Misfolded proteins partition 
between two distinct quality control compartments. Nature. 454:1088–
1095. http://dx.doi.org/10.1038/nature07195
Kama, R., M. Robinson, and J.E. Gerst. 2007. Btn2, a Hook1 ortholog and 
potential Batten disease­related protein, mediates late endosome­Golgi 
protein sorting in yeast. Mol. Cell. Biol. 27:605–621. http://dx.doi.org/ 
10.1128/MCB.00699­06
Kanneganti, V., R. Kama, and J.E. Gerst. 2011. Btn3 is a negative regulator 
of  Btn2­mediated  endosomal  protein  trafficking  and  prion  curing  in 
yeast.  Mol.  Biol.  Cell.  22:1648–1663.  http://dx.doi.org/10.1091/mbc 
.E10­11­0878
Kim, Y., S. Chattopadhyay, S. Locke, and D.A. Pearce. 2005. Interaction among 
Btn1p, Btn2p, and Ist2p reveals potential interplay among the vacuole, 
amino acid levels, and ion homeostasis in the yeast Saccharomyces cere-
visiae. Eukaryot. Cell. 4:281–288. http://dx.doi.org/10.1128/EC.4.2.281­ 
288.2005
Krämer, H., and M. Phistry. 1996. Mutations in the Drosophila hook gene inhibit 
endocytosis of the boss transmembrane ligand into multivesicular bodies.   
J. Cell Biol. 133:1205–1215. http://dx.doi.org/10.1083/jcb.133.6.1205
Kryndushkin,  D.S.,  F.  Shewmaker,  and  R.B.  Wickner.  2008.  Curing  of  the 
[URE3]  prion  by  Btn2p,  a  Batten  disease­related  protein.  EMBO  J. 
27:2725–2735. http://dx.doi.org/10.1038/emboj.2008.198
Kyttälä, A., U. Lahtinen, T. Braulke, and S.L. Hofmann. 2006. Functional bi­
ology of the neuronal ceroid lipofuscinoses (NCL) proteins. Biochim. 
Biophys. Acta. 1762:920–933.
LaGrassa, T.J., and C. Ungermann. 2005. The vacuolar kinase Yck3 maintains 
organelle  fragmentation  by  regulating  the  HOPS  tethering  complex.   
J. Cell Biol. 168:401–414. http://dx.doi.org/10.1083/jcb.200407141
Longtine,  M.S., A.  McKenzie  III,  D.J.  Demarini,  N.G.  Shah, A.  Wach, A. 
Brachat, P. Philippsen, and J.R. Pringle. 1998. Additional modules for 
versatile and economical PCR­based gene deletion and modification in 
Saccharomyces cerevisiae. Yeast. 14:953–961. http://dx.doi.org/10.1002/
(SICI)1097­0061(199807)14:10<953::AID­YEA293>3.0.CO;2­U
Matern, H., X. Yang, E. Andrulis, R. Sternglanz, H.H. Trepte, and D. Gallwitz. 
2000. A  novel  Golgi  membrane  protein  is  part  of  a  GTPase­binding 
protein complex involved in vesicle targeting. EMBO J. 19:4485–4492. 
http://dx.doi.org/10.1093/emboj/19.17.4485
Metcalf, D.J., A.A. Calvi, M.Nj. Seaman, H.M. Mitchison, and D.F. Cutler. 
2008. Loss of the Batten disease gene CLN3 prevents exit from the TGN 
of the mannose 6­phosphate receptor. Traffic. 9:1905–1914. http://dx.doi 
.org/10.1111/j.1600­0854.2008.00807.x
Mole, S.E., R.E. Williams, and H.H. Goebel. 2005. Correlations between geno­
type, ultrastructural morphology and clinical phenotype in the neuronal 
ceroid lipofuscinoses. Neurogenetics. 6:107–126. http://dx.doi.org/10.1007/ 
s10048­005­0218­3
Narayan, S.B., D. Rakheja, L. Tan, J.V. Pastor, and M.J. Bennett. 2006. CLN3P, 
the Batten’s disease protein, is a novel palmitoyl­protein ­9 desaturase. 
Ann. Neurol. 60:570–577. http://dx.doi.org/10.1002/ana.20975
Narayan, S.B., L. Tan, and M.J. Bennett. 2008. Intermediate levels of neuro­
nal  palmitoyl­protein  ­9  desaturase  in  heterozygotes  for  murine 
Batten disease. Mol. Genet. Metab. 93:89–91. http://dx.doi.org/10.1016/ 
j.ymgme.2007.09.005
We thank H. Abeliovich, D. Banfield, G. Fischer von Mollard, S. Keranen,   
H. Pelham, and T. LaGrassa for reagents.
This study was supported by grants to J.E. Gerst from the Israel Science 
Foundation (188/07 and 358/10), Y. Leon Benoziyo Institute for Molecular 
Medicine, Irving B. Harris Foundation, and Weizmann Institute of Science and 
to V. Kanneganti and J.E. Gerst from the National Contest for Life Foundation. 
C. Ungermann is supported by grants from the Deutsche Forschungsgemein-
schaft (SFB 944 and 431) and Hans-Mühlenhoff Foundation. J.E. Gerst holds 
the Besen-Brender Chair of Microbiology and Parasitology.
Submitted: 22 February 2011
Accepted: 16 September 2011
References
Abeliovich, H., E. Grote, P. Novick, and S. Ferro­Novick. 1998. Tlg2p, a yeast syn­
taxin homolog that resides on the Golgi and endocytic structures. J. Biol. 
Chem. 273:11719–11727. http://dx.doi.org/10.1074/jbc.273.19.11719
Bagola,  K.,  and  T.  Sommer.  2008.  Protein  quality  control:  On  IPODs  and 
other  JUNQ.  Curr.  Biol.  18:R1019–R1021.  http://dx.doi.org/10.1016/ 
j.cub.2008.09.036
Banfield, D.K., M.J. Lewis, C. Rabouille, G. Warren, and H.R. Pelham. 1994. 
Localization of Sed5, a putative vesicle targeting molecule, to the cis­
Golgi network involves both its transmembrane and cytoplasmic domains. 
J. Cell Biol. 127:357–371. http://dx.doi.org/10.1083/jcb.127.2.357
Brett, C.L., R.L. Plemel, B.T. Lobinger, M. Vignali, S. Fields, and A.J. Merz. 
2008. Efficient termination of vacuolar Rab GTPase signaling requires 
coordinated action by a GAP and a protein kinase. J. Cell Biol. 182:1141–
1151. http://dx.doi.org/10.1083/jcb.200801001
Brickner, J.H., and R.S. Fuller. 1997. SOI1 encodes a novel, conserved protein 
that promotes TGN–endosomal cycling of Kex2p and other membrane 
proteins by modulating the function of two TGN localization signals.   
J. Cell Biol. 139:23–36. http://dx.doi.org/10.1083/jcb.139.1.23
Bugnicourt, A., M. Froissard, K. Sereti, H.D. Ulrich, R. Haguenauer­Tsapis, and 
J.M. Galan. 2004. Antagonistic roles of ESCRT and Vps class C/HOPS 
complexes in the recycling of yeast membrane proteins. Mol. Biol. Cell. 
15:4203–4214. http://dx.doi.org/10.1091/mbc.E04­05­0420
Cabrera,  M.,  C.W.  Ostrowicz,  M.  Mari,  T.J.  LaGrassa,  F.  Reggiori,  and  C. 
Ungermann. 2009. Vps41 phosphorylation and the Rab Ypt7 control the 
targeting of the HOPS complex to endosome­vacuole fusion sites. Mol. 
Biol. Cell. 20:1937–1948. http://dx.doi.org/10.1091/mbc.E08­09­0943
Cabrera, M., L. Langemeyer, M. Mari, R. Rethmeier, I. Orban, A. Perz, C. 
Bröcker, J. Griffith, D. Klose, H.J. Steinhoff, et al. 2010. Phosphorylation 
of a membrane curvature­sensing motif switches function of the HOPS 
subunit Vps41 in membrane tethering. J. Cell Biol. 191:845–859. http://
dx.doi.org/10.1083/jcb.201004092
Chattopadhyay, S., and D.A. Pearce. 2002. Interaction with Btn2p is required 
for localization of Rsglp: Btn2p­mediated changes in arginine uptake 
in Saccharomyces cerevisiae. Eukaryot. Cell. 1:606–612. http://dx.doi 
.org/10.1128/EC.1.4.606­612.2002
Chattopadhyay, S., N.E. Muzaffar, F. Sherman, and D.A. Pearce. 2000. The yeast 
model for batten disease: Mutations in BTN1, BTN2, and HSP30 alter 
pH homeostasis. J. Bacteriol. 182:6418–6423. http://dx.doi.org/10.1128/ 
JB.182.22.6418­6423.2000
Chattopadhyay, S., P.M. Roberts, and D.A. Pearce. 2003. The yeast model for 
Batten disease: A role for Btn2p in the trafficking of the Golgi­associated 
vesicular targeting protein, Yif1p. Biochem. Biophys. Res. Commun. 302: 
534–538. http://dx.doi.org/10.1016/S0006­291X(03)00209­2
Codlin, S., and S.E. Mole. 2009. S. pombe btn1, the orthologue of the Batten 
disease gene CLN3, is required for vacuole protein sorting of Cpy1p 
and Golgi exit of Vps10p. J. Cell Sci. 122:1163–1173. http://dx.doi.org/ 
10.1242/jcs.038323
Coe, J.G., A.C. Lim, J. Xu, and W. Hong. 1999. A role for Tlg1p in the transport 
of proteins within the Golgi apparatus of Saccharomyces cerevisiae. Mol. 
Biol. Cell. 10:2407–2423.
Croopnick, J.B., H.C. Choi, and D.M. Mueller. 1998. The subcellular location of 
the yeast Saccharomyces cerevisiae homologue of the protein defective 
in the juvenile form of Batten disease. Biochem. Biophys. Res. Commun. 
250:335–341. http://dx.doi.org/10.1006/bbrc.1998.9272
Deloche, O., and R.W. Schekman. 2002. Vps10p cycles between the TGN and 
the late endosome via the plasma membrane in clathrin mutants. Mol. 
Biol. Cell. 13:4296–4307. http://dx.doi.org/10.1091/mbc.02­07­0105
Fischer von Mollard, G., and T.H. Stevens. 1999. The Saccharomyces cerevisiae 
v­SNARE Vti1p is required for multiple membrane transport pathways to 
the vacuole. Mol. Biol. Cell. 10:1719–1732.
Gachet, Y.,  S.  Codlin,  J.S.  Hyams,  and  S.E.  Mole.  2005.  btn1,  the  Schizo-
saccharomyces  pombe  homologue  of  the  human  Batten  disease  gene 215 Btn1 regulates endosome–Golgi retrograde transport • Kama et al.
Weinberger, A., F. Kamena, R. Kama, A. Spang, and J.E. Gerst. 2005. Control of 
Golgi morphology and function by Sed5 t­SNARE phosphorylation. Mol. 
Biol. Cell. 16:4918–4930. http://dx.doi.org/10.1091/mbc.E05­02­0101
Wolfe, D.M., S. Padilla­Lopez, S.P. Vitiello, and D.A. Pearce. 2011. pH­ 
dependent localization of Btn1p in the yeast model for Batten disease. 
Dis Model Mech. 4:120–125. http://dx.doi.org/10.1242/dmm.006114
Ohno, Y., A. Kihara, T. Sano, and Y. Igarashi. 2006. Intracellular localization 
and tissue­specific distribution of human and yeast DHHC cysteine­rich 
domain­containing proteins. Biochim. Biophys. Acta. 1761:474–483.
Osório, N.S., A. Carvalho, A.J. Almeida, S. Padilla­Lopez, C. Leão, J. Laranjinha, 
P. Ludovico, D.A. Pearce, and F. Rodrigues. 2007. Nitric oxide signal­
ing is disrupted in the yeast model for Batten disease. Mol. Biol. Cell. 
18:2755–2767. http://dx.doi.org/10.1091/mbc.E06­11­1053
Padilla­López, S., and D.A. Pearce. 2006. Saccharomyces cerevisiae lacking 
Btn1p modulate vacuolar ATPase activity to regulate pH imbalance in the 
vacuole. J. Biol. Chem. 281:10273–10280. http://dx.doi.org/10.1074/jbc 
.M510625200
Pearce, D.A., and F. Sherman. 1997. BTN1, a yeast gene corresponding to the 
human gene responsible for Batten’s disease, is not essential for viabil­
ity, mitochondrial function, or degradation of mitochondrial ATP syn­
thase. Yeast. 13:691–697. http://dx.doi.org/10.1002/(SICI)1097­0061 
(19970630)13:8<691::AID­YEA123>3.0.CO;2­D
Pearce, D.A., and F. Sherman. 1998. A yeast model for the study of Batten 
disease.  Proc.  Natl. Acad.  Sci.  USA.  95:6915–6918.  http://dx.doi.org/ 
10.1073/pnas.95.12.6915
Pearce, D.A., and F. Sherman. 1999. Investigation of Batten disease with the 
yeast Saccharomyces cerevisiae. Mol. Genet. Metab. 66:314–319. http://
dx.doi.org/10.1006/mgme.1999.2820
Pearce, D.A., T. Ferea, S.A. Nosel, B. Das, and F. Sherman. 1999. Action of 
BTN1, the yeast orthologue of the gene mutated in Batten disease. Nat. 
Genet. 22:55–58. http://dx.doi.org/10.1038/8861
Phillips, S.N., J.W. Benedict, J.M. Weimer, and D.A. Pearce. 2005. CLN3, the 
protein associated with batten disease: structure, function and localiza­
tion. J. Neurosci. Res. 79:573–583. http://dx.doi.org/10.1002/jnr.20367
Piper, R.C., A.A. Cooper, H. Yang, and T.H. Stevens. 1995. VPS27 controls 
vacuolar  and  endocytic  traffic  through  a  prevacuolar  compartment  in 
Saccharomyces  cerevisiae.  J.  Cell  Biol.  131:603–617.  http://dx.doi 
.org/10.1083/jcb.131.3.603
Protopopov, V., B. Govindan, P. Novick, and J.E. Gerst. 1993. Homologs of the 
synaptobrevin/VAMP family of synaptic vesicle proteins function on the 
late secretory pathway in S. cerevisiae. Cell. 74:855–861. http://dx.doi.org/ 
10.1016/0092­8674(93)90465­3
Rakheja, D., S.B. Narayan, and M.J. Bennett. 2008. The function of CLN3P, 
the Batten disease protein. Mol. Genet. Metab. 93:269–274. http://dx.doi 
.org/10.1016/j.ymgme.2008.01.001
Richardson, S.C., S.C. Winistorfer, V. Poupon, J.P. Luzio, and R.C. Piper. 2004. 
Mammalian late vacuole protein sorting orthologues participate in early 
endosomal fusion and interact with the cytoskeleton. Mol. Biol. Cell. 
15:1197–1210. http://dx.doi.org/10.1091/mbc.E03­06­0358
Rose, M.D., F. Winston, and P. Hieter. 1990. Methods in Yeast Genetics: A 
Laboratory Course Manual. Cold Spring Harbor Laboratory Press, Cold 
Spring Harbor, NY. 198 pp.
Seaman, M.N., J.M. McCaffery, and S.D. Emr. 1998. A membrane coat com­
plex essential for endosome­to­Golgi retrograde transport in yeast. J. Cell 
Biol. 142:665–681. http://dx.doi.org/10.1083/jcb.142.3.665
Siintola, E., A.E. Lehesjoki, and S.E. Mole. 2006. Molecular genetics of the   
NCLs — status and perspectives. Biochim. Biophys. Acta. 1762:857–864.
Stefan, C.J., and K.J. Blumer. 1999. A syntaxin homolog encoded by VAM3 
mediates down­regulation of a yeast G protein­coupled receptor. J. Biol. 
Chem. 274:1835–1841. http://dx.doi.org/10.1074/jbc.274.3.1835
Sun, B., L. Chen, W. Cao, A.F. Roth, and N.G. Davis. 2004. The yeast casein ki­
nase Yck3p is palmitoylated, then sorted to the vacuolar membrane with 
AP­3­dependent recognition of a YXXPhi adaptin sorting signal. Mol. 
Biol. Cell. 15:1397–1406. http://dx.doi.org/10.1091/mbc.E03­09­0682
Sunio, A., A.B. Metcalf, and H. Krämer. 1999. Genetic dissection of endocytic 
trafficking in Drosophila using a horseradish peroxidase­bride of seven­
less chimera: Hook is required for normal maturation of multivesicular 
endosomes. Mol. Biol. Cell. 10:847–859.
Vesa,  J.,  E.  Hellsten,  L.A. Verkruyse,  L.A.  Camp,  J.  Rapola,  P.  Santavuori, 
S.L. Hofmann, and L. Peltonen. 1995. Mutations in the palmitoyl pro­
tein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. 
Nature. 376:584–587. http://dx.doi.org/10.1038/376584a0
Vitiello,  S.P.,  J.W.  Benedict,  S.  Padilla­Lopez,  and  D.A.  Pearce.  2010. 
Interaction between Sdo1p and Btn1p in the Saccharomyces cerevisiae 
model for Batten disease. Hum. Mol. Genet. 19:931–942. http://dx.doi 
.org/10.1093/hmg/ddp560
Walenta, J.H., A.J. Didier, X. Liu, and H. Krämer. 2001. The Golgi­associated 
hook3 protein is a member of a novel family of microtubule­binding pro­
teins. J. Cell Biol. 152:923–934. http://dx.doi.org/10.1083/jcb.152.5.923
Wang, X., M.F. Hoekstra, A.J. DeMaggio, N. Dhillon, A. Vancura, J. Kuret, G.C. 
Johnston, and R.A. Singer. 1996. Prenylated isoforms of yeast casein 
kinase I, including the novel Yck3p, suppress the gcs1 blockage of cell 
proliferation from stationary phase. Mol. Cell. Biol. 16:5375–5385.